Praxis Precision Medicines Inc. (NASDAQ
RAX) stock rose Monday after the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) for ulixacaltamide for essential tremor (ET). Essential Tremor is the most common movement disorder, affecting roughly seven million…Continue reading...